Recent Advances in the Diagnosis of Neurocysticercosis

Gadea, Nicholas A.; Matamoros, Gabriela; Rueda, María Mercedes

doi:10.1007/s40506-018-0173-9

Cited by 2 publications

(1 citation statement)

References 60 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two monoclonal antibody-based tests are standardized: B158/B60 Ag-ELISA and HP10. Antigen detection assays can also be used to monitor the efficacy of anthelminthic drugs and differentiate between viable parasites and locate them in the central nervous system [32]. A 2020 study by Kabululu et al observed that the B158/B60 monoclonal-based sandwich enzyme-linked immunosorbent assay (Ag-ELISA) was more reliable in ruling out T. s o l i u m cysticercosis in pigs [33].…”

Section: Serologic Diagnosismentioning

confidence: 99%

Advances in the Diagnosis of Cysticercosis

Mohammad Tawfeeq

2024

Infectious Diseases

View full text Add to dashboard Cite

Human cysticercosis is one of the most pathogenic and lethal diseases. It is caused by the accidental ingestion of Taenia solium eggs. All Taenia species lead to cysticercosis in animals; T. solium and Torenia asiatica are responsible for cysticercosis in pigs, while T. saginata causes bovine cysticercosis. Cysticercosis in humans is considered a neglected tropical disease. Diagnosing taeniasis—an infection with the adult parasite—poses challenges. The clinical manifestations of the disease are nonspecific, and no easy method is available to confirm the diagnosis. The diagnosis of cysticercosis is mainly based on imaging techniques, including computed tomography and magnetic resonance. These techniques are valuable and accurate but sometimes limited due to atypical images that are difficult to distinguish from neoplasms. Therefore, sensitive and specific methods, such as immunological tests and molecular methods, are essential to confirm clinical findings and differentiate cysticercosis from other diseases.

show abstract

Section: Serologic Diagnosismentioning

confidence: 99%